seed
Stage
1
Investors
About
AxCell Labs is a Canadian medical device company developing regenerative soft-tissue implants made from a bacterial cellulose–derived biomaterial, including a regenerative dermal injectable. The company has completed preclinical biocompatibility studies, filed a PCT patent, raised seed funding, and is preparing regulatory preclinical studies toward first-in-human trials.
Explore AxCell Labs's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.